No products in the cart.
#VisualAbstract: Induction chemotherapy with erlotinib does not improve survival in stage III-IV head and neck squamous cell carcinoma
Click to read this study in Clinical Cancer Research.
#VisualAbstract: Induction chemotherapy with cisplatin plus gemcitabine in addition to concurrent chemotherapy improves survival for nasopharyngeal carcinoma
Click to read this study in the Journal of Clinical Oncology.
#VisualAbstract: Pembrolizumab-based therapy is more effective with increasing PD-L1 expression in head and neck squamous cell carcinomas
Click to read this study in the Journal of Clinical Oncology.
#VisualAbstract: Use of prophylactic compression sleeves reduces arm swelling in patients with breast cancer undergoing axillary lymph node dissection
Click to read this study in the Journal of Clinical Oncology.
#VisualAbstract: Capivasertib in addition to fulvestrant improves progression-free survival in ER⁺ advanced breast cancer
Click to read this study in The Lancet Oncology.
#VisualAbstract: Addition of selumetinib to radioactive iodine does not improve remission rates in differentiated thyroid cancers
Click to read this study in the Journal of Clinical Oncology.
#VisualAbstract: Addition of denosumab to neoadjuvant paclitaxel does not improve complete response rate in breast cancer
Click to read this study in JAMA Oncology.
#VisualAbstract: Once-weekly cisplatin is noninferior to cisplatin every 3 weeks for postoperative head and neck cancers
Click to read this study in the Journal of Clinical Oncology.
#VisualAbstract: Maintenance endocrine therapy plus bevacizumab after induction with paclitaxel is effective for ER+ breast cancers
Click to read this study in The Lancet Oncology.
#VisualAbstract: Combination of spartalizumab plus dabrafenib and trametinib does not significantly improve survival in BRAFV600-mutated metastatic melanoma
Click to read this study in the Journal of Clinical Oncology.
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.